Clinical Trial

Hysteroscopic "360°" Surgery for Improvement of Symptoms in Cesarean Scar Defects

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Patients with symptomatic Cesarean Scar Defect (CSD) who are expected to undergo hysteroscopic surgery will be randomly divided into the traditional hysteroscopic "channelization" treatment group and the hysteroscopic "360 °" Surgery group of cesarean diverticulum, and the improvement of postoperative clinical symptoms of the two groups will be compared. To evaluate the effectiveness of the two surgical methods. The purpose of this study was to evaluate the improvement of symptoms of women with symptomatic cesarean diverticulum through a high-quality randomized controlled study, in order to provide high-level evidence-based medical evidence for clinical treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-01.
Trial Details
NCT Number NCT06917014
Lead Sponsor Fu Xing Hospital, Capital Medical University
Conditions Cesarean Scar Defect
Enrollment 88 participants
Start Date 2025-05-16
Primary Completion 2029-11 (estimated)
Study Completion 2029-11 (estimated)
Updated on ClinicalTrials.gov 2025-05-16